BioDelivery Sciences International Inc
NASDAQ:BDSI
BioDelivery Sciences International Inc
NASDAQ:BDSI
Price:
5.59 USD
-0.09%
Market Closed
Updated:
May 31, 2024
Balance Sheet
Balance Sheet Decomposition
BioDelivery Sciences International Inc
BioDelivery Sciences International Inc
| Current Assets | 202.1m |
| Cash & Short-Term Investments | 114.3m |
| Receivables | 56.9m |
| Other Current Assets | 30.9m |
| Non-Current Assets | 122.5m |
| PP&E | 1.7m |
| Intangibles | 61.5m |
| Other Non-Current Assets | 59.2m |
| Current Liabilities | 82.4m |
| Accounts Payable | 8.1m |
| Accrued Liabilities | 69m |
| Other Current Liabilities | 5.3m |
| Non-Current Liabilities | 54.4m |
| Long-Term Debt | 54.2m |
| Other Non-Current Liabilities | 219k |
Balance Sheet
BioDelivery Sciences International Inc
BioDelivery Sciences International Inc
Currency: USD
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
63
|
23
|
71
|
84
|
32
|
21
|
44
|
64
|
112
|
114
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
44
|
64
|
0
|
0
|
|
| Cash Equivalents |
63
|
23
|
71
|
84
|
32
|
21
|
0
|
0
|
112
|
114
|
|
| Total Receivables |
1
|
3
|
3
|
3
|
3
|
9
|
14
|
39
|
48
|
57
|
|
| Accounts Receivables |
1
|
3
|
3
|
3
|
3
|
9
|
14
|
39
|
48
|
57
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
2
|
3
|
3
|
6
|
5
|
11
|
17
|
24
|
|
| Other Current Assets |
0
|
1
|
3
|
4
|
4
|
4
|
3
|
4
|
5
|
7
|
|
| Total Current Assets |
64
|
27
|
78
|
93
|
43
|
40
|
66
|
118
|
182
|
202
|
|
| PP&E Net |
3
|
3
|
4
|
4
|
4
|
4
|
3
|
2
|
1
|
2
|
|
| PP&E Gross |
3
|
3
|
4
|
4
|
4
|
4
|
3
|
2
|
1
|
2
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
3
|
3
|
4
|
6
|
5
|
5
|
|
| Intangible Assets |
6
|
5
|
4
|
3
|
2
|
42
|
37
|
60
|
53
|
62
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
57
|
|
| Other Assets |
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Total Assets |
76
N/A
|
38
-50%
|
89
+134%
|
103
+16%
|
52
-50%
|
88
+70%
|
109
+23%
|
183
+69%
|
240
+31%
|
325
+35%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
9
|
10
|
9
|
12
|
3
|
12
|
4
|
8
|
|
| Accrued Liabilities |
0
|
0
|
5
|
9
|
8
|
14
|
18
|
42
|
49
|
69
|
|
| Short-Term Debt |
0
|
7
|
8
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Other Current Liabilities |
13
|
7
|
7
|
2
|
2
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
23
|
25
|
29
|
28
|
19
|
26
|
22
|
54
|
53
|
82
|
|
| Long-Term Debt |
0
|
12
|
4
|
22
|
29
|
48
|
52
|
59
|
79
|
54
|
|
| Other Liabilities |
3
|
2
|
2
|
21
|
21
|
5
|
6
|
1
|
0
|
0
|
|
| Total Liabilities |
26
N/A
|
39
+49%
|
34
-11%
|
71
+107%
|
69
-2%
|
79
+14%
|
79
-1%
|
113
+44%
|
132
+16%
|
137
+4%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
94
|
151
|
206
|
243
|
310
|
305
|
351
|
367
|
341
|
256
|
|
| Additional Paid In Capital |
144
|
151
|
260
|
275
|
293
|
314
|
381
|
436
|
449
|
456
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
|
| Total Equity |
50
N/A
|
1
N/A
|
54
N/A
|
32
-42%
|
18
N/A
|
9
N/A
|
30
+234%
|
70
+135%
|
108
+55%
|
188
+74%
|
|
| Total Liabilities & Equity |
76
N/A
|
38
-50%
|
89
+134%
|
103
+16%
|
52
-50%
|
88
+70%
|
109
+23%
|
183
+69%
|
240
+31%
|
325
+35%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
38
|
38
|
52
|
53
|
54
|
56
|
71
|
96
|
101
|
99
|
|
| Preferred Shares Outstanding |
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
